Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAL vs Zoledronic Acid in Breast Cancer Bone Metastases
NCT00060138Phase 2Completed
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Nov 2002
- Primary completion
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid in breast cancer, bone metastasis, sponsored by Chugai Pharmaceutical Co., Ltd.. Started Nov 2002; status: completed.
02
Drugs
5-amino-6-cyclohexyl-4-hydroxy-2-isobutyl-hexanoic acid
03
Conditions
breast cancerbone metastasis
Beyond the preview
Go deeper on NCT00060138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060138.